Medtronic begins renal denervation study for high blood pressure patients
Medtronic announced FDA approval to begin a clinical trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension) who are already prescribed anti-hypertension medications. November 08, 2018